medical guideline
首页
中医/中西医结合指南
肿瘤学指南
泌尿外科指南
关于我们
郑重声明
联系我们
首页
肿瘤学指南
检索结果
人体系统
运动
骨肿瘤
软组织肿瘤
骨与软组织肿瘤
硬纤维瘤
骶尾部畸胎瘤
神经
中枢神经系统肿瘤
嗜铬细胞瘤和副神经节瘤
副神经节瘤
胶质细胞瘤
前庭神经鞘瘤
星形胶质细胞瘤和少突胶质细胞瘤
弥漫性胶质瘤
神经纤维瘤
神经细胞瘤
神经内分泌肿瘤
内分泌
甲状腺肿瘤
垂体肿瘤
肾上腺肿瘤
甲状旁腺肿瘤
胸腺肿瘤
神经内分泌肿瘤
循环
心脏肿瘤
淋巴瘤
骨髓瘤
白血病
血液肿瘤
血管瘤
呼吸
肺癌
鼻咽癌
喉部肿瘤
下咽癌
鼻腔和副鼻窦癌
呼吸道肿瘤
鼻颅咽管瘤
淋巴管肌瘤
消化
胰腺肿瘤
口腔癌
肛门癌
口咽癌
胆囊癌
胆管肿瘤
直肠癌
结肠癌
胃癌
小肠癌
肝癌
大肠肿瘤
唾液腺癌
阑尾肿瘤
食管肿瘤
肝肿瘤
壶腹肿瘤
肝胆癌
结直肠肿瘤
食管胃肿瘤
胃肠道肿瘤
消化道肿瘤
泌尿
膀胱肿瘤
肾癌
脐尿管癌
尿路上皮癌
肾血管平滑肌脂肪瘤
泌尿生殖肿瘤
生殖
女性
子宫肿瘤
卵巢肿瘤
乳腺肿瘤
阴道肿瘤
输卵管癌
外阴癌
妊娠滋养细胞肿瘤
妇科肿瘤
男性
前列腺肿瘤
性索间质瘤
睾丸肿瘤
阴茎癌
男性乳腺肿瘤
泌尿生殖肿瘤
其他
症状管理
治疗方案
诊断/检测/评估方法
预防和筛查
COVID-19大流行癌症患者相关指导建议
皮肤肿瘤
黑色素瘤
头颈部肿瘤
康复营养
生育能力
体力活动
心理健康
腹膜肿瘤
实体瘤
胸部肿瘤
长期监测
Cowden综合征
转诊
遗传性癌症综合征
癌症患者其他类问题管理
寡转移性疾病
基因测序
易感基因变异的分类
外科肿瘤
罕见癌症
不明原因癌症
纤维瘤
腹部肿瘤
老年肿瘤
儿童/青少年肿瘤
人类微生物组与癌变
检索结果
按关键字
按标题
按关键词
按摘要
按作者
按期刊
按发表年份
共搜索到
52条
与
Primary
有关的结果
Primary Cutaneous Lymphomas
2021年 发布于
National Comprehensive Cancer Network
卷 第期
所属人体系统：
循环
|
淋巴瘤
National Comprehensive Cancer Network
Primary
Cutaneous Lymphomas
Mycosis Fungoides
Sezary Syndrome
Primary
Cutaneous B-Cell Lymphomas
Primary
Cutaneous CD30+ T-Cell Lymphoproliferative Disorders
diagnosis
supportive Care
radiation Therapy
指南简介
原文链接
The 2020 Japan Society of Gynecologic Oncology Guidelines for the Treatment of Ovarian Cancer, Fallopian Tube Cancer, and Primary Peritoneal Cancer
2021年 发布于
Journal of Gynecologic Oncology
32卷 第2期
所属人体系统：
其他
|
腹膜肿瘤
Japan Society of Gynecologic Oncology
The Fifth Edition of the Japan Society of Gynecologic Oncology Guidelines for the Treatment of Ovarian Cancer
Fallopian Tube Cancer
and
Primary
Peritoneal Cancer Was Published in 2020. the Guidelines Contain 6 Chapters-namely
(1) Overview of the Guidelines
(2) Epithelial Ovarian Cancer
Fallopian Tube Cancer
and
Primary
Peritoneal Cancer
(3) Recurrent Epithelial Ovarian Cancer
Fallopian Tube Cancer
and
Primary
Peritoneal Cancer
(4) Borderline Epithelial Tumors of the Ovary
(5) Malignant Germ Cell Tumors of the Ovary
and (6) Malignant Sex Cord-stromal Tumors. Furthermore
the Guidelines Comprise 5 Algorithms-namely
(1) Initial Treatment for Ovarian Cancer
Fallopian Tube Cancer
and
Primary
Peritoneal Cancer
(2) Treatment for Recurrent Ovarian Cancer
Fallopian Tube Cancer
and
Primary
Peritoneal Cancer
(3) Initial Treatment for Borderline Epithelial Ovarian Tumor
(4) Treatment for Malignant Germ Cell Tumor
and (5) Treatment for Sex Cord-stromal Tumor. Major Changes in the New Edition Include the Following: (1) Revision of the Title to "guidelines for the Treatment of Ovarian Cancer
Fallopian Tube Cancer
and
Primary
Peritoneal Cancer"
(2) Involvement of Patients and General (male/female) Participants in Addition to Physicians
Pharmacists
and Nurses
(3) Clinical Questions (CQs) in the PICO Format
(4) Change in the Expression of Grades of Recommendation and Level of Evidence in Accordance with the GRADE System
(5) Introduction of the Idea of a Body of Evidence
(6) Categorization of References According to Research Design
(7) Performance of Systematic Reviews and Meta-analysis for Three CQs
and (8) Voting for Each CQ/recommendation and Description of the Consensus.
指南简介
原文链接
An Ontario Health (Cancer Care Ontario) Clinical Practice Guideline: Consolidation Or Maintenance Systemic Therapy for Newly Diagnosed Stage Ii, Iii, Or Iv Epithelial Ovary, Fallopian Tube, Or Primary Peritoneal Carcinoma
2021年 发布于
Current Oncology
28卷 第2期
所属人体系统：
其他
|
腹膜肿瘤
Ontario Health (Cancer Care Ontario)
Objective: to Provide Recommendations on Systemic Therapy Options in Consolidation Or Maintenance Therapy for Women with Newly Diagnosed Stage II
III
Or IV Epithelial Ovary
Fallopian Tube
Or
Primary
Peritoneal Carcinoma Including All Histological Types.
Methods: Consistent with the Program in Evidence-based Program's Standardized Approach
MEDLINE
EMBASE
PubMed
Cochrane Library
and PROSPERO (the International Prospective Register of Systematic Reviews) Databases
and Four Relevant Conferences Were Systematically Searched. the Working Group Drafted Recommendations and Revised Them Based on the Comments from Internal and External Reviewers.
Results: We Have One Recommendation for Consolidation Therapy and Eight Recommendations for Maintenance Therapy. Overall
Consolidation Therapy with Chemotherapy Should Not Be Recommended in the Target Population. for Maintenance Therapy
We Recommended Olaparib (Recommendation)
Niraparib (Weak Recommendation)
Veliparib (Weak Recommendation)
and Bevacizumab (Weak Recommendation) for Certain Patients with Newly Diagnosed Stage III-IV Epithelial Ovarian
Fallopian Tube
Or
Primary
Peritoneal Carcinoma
Respectively. We Do Not Recommend Some Agents as Maintenance Therapy in Four Recommendations. We Are Unable to Specify the Patient Population by Histological Types for Different Maintenance Therapy Recommendations. When New Evidence That Can Impact the Recommendations Is Available
the Recommendations Will Be Updated as Soon as Possible.
指南简介
原文链接
The 2020 Revision of the Guidelines for the Management of Myeloproliferative Neoplasms
2021年 发布于
Korean Journal of Internal Medicine
36卷 第1期
所属人体系统：
循环
|
骨髓瘤
World Health Organization
Polycythemia Vera
Practice Guideline
Primary
Myelofibrosis
Thrombocythemia
Essential.
指南简介
原文链接
Esophageal and Esophagogastric Junction Cancers
2021年 发布于
National Comprehensive Cancer Network
卷 第期
所属人体系统：
消化
|
食管胃肿瘤
National Comprehensive Cancer Network
Esophageal Cancers
Esophagogastric Junction Cancers
treatment
primary Treatment
chemoradiation
follow-up
non-surgical
radiation Therapy
systemic Therapy
supportive Care
指南简介
原文链接
The 2020 Japan Society of Gynecologic Oncology Guidelines for the Treatment of Ovarian Cancer, Fallopian Tube Cancer, and Primary Peritoneal Cancer
2021年 发布于
Journal of Gynecologic Oncology
32卷 第2期
所属人体系统：
生殖
|
输卵管癌
Japan Society of Gynecologic Oncology
The Fifth Edition of the Japan Society of Gynecologic Oncology Guidelines for the Treatment of Ovarian Cancer
Fallopian Tube Cancer
and
Primary
Peritoneal Cancer Was Published in 2020. the Guidelines Contain 6 Chapters-namely
(1) Overview of the Guidelines
(2) Epithelial Ovarian Cancer
Fallopian Tube Cancer
and
Primary
Peritoneal Cancer
(3) Recurrent Epithelial Ovarian Cancer
Fallopian Tube Cancer
and
Primary
Peritoneal Cancer
(4) Borderline Epithelial Tumors of the Ovary
(5) Malignant Germ Cell Tumors of the Ovary
and (6) Malignant Sex Cord-stromal Tumors. Furthermore
the Guidelines Comprise 5 Algorithms-namely
(1) Initial Treatment for Ovarian Cancer
Fallopian Tube Cancer
and
Primary
Peritoneal Cancer
(2) Treatment for Recurrent Ovarian Cancer
Fallopian Tube Cancer
and
Primary
Peritoneal Cancer
(3) Initial Treatment for Borderline Epithelial Ovarian Tumor
(4) Treatment for Malignant Germ Cell Tumor
and (5) Treatment for Sex Cord-stromal Tumor. Major Changes in the New Edition Include the Following: (1) Revision of the Title to "guidelines for the Treatment of Ovarian Cancer
Fallopian Tube Cancer
and
Primary
Peritoneal Cancer"
(2) Involvement of Patients and General (male/female) Participants in Addition to Physicians
Pharmacists
and Nurses
(3) Clinical Questions (CQs) in the PICO Format
(4) Change in the Expression of Grades of Recommendation and Level of Evidence in Accordance with the GRADE System
(5) Introduction of the Idea of a Body of Evidence
(6) Categorization of References According to Research Design
(7) Performance of Systematic Reviews and Meta-analysis for Three CQs
and (8) Voting for Each CQ/recommendation and Description of the Consensus.
指南简介
原文链接
An Ontario Health (Cancer Care Ontario) Clinical Practice Guideline: Consolidation Or Maintenance Systemic Therapy for Newly Diagnosed Stage Ii, Iii, Or Iv Epithelial Ovary, Fallopian Tube, Or Primary Peritoneal Carcinoma
2021年 发布于
Current Oncology
28卷 第2期
所属人体系统：
生殖
|
输卵管癌
Ontario Health (Cancer Care Ontario)
Objective: to Provide Recommendations on Systemic Therapy Options in Consolidation Or Maintenance Therapy for Women with Newly Diagnosed Stage II
III
Or IV Epithelial Ovary
Fallopian Tube
Or
Primary
Peritoneal Carcinoma Including All Histological Types.
Methods: Consistent with the Program in Evidence-based Program's Standardized Approach
MEDLINE
EMBASE
PubMed
Cochrane Library
and PROSPERO (the International Prospective Register of Systematic Reviews) Databases
and Four Relevant Conferences Were Systematically Searched. the Working Group Drafted Recommendations and Revised Them Based on the Comments from Internal and External Reviewers.
Results: We Have One Recommendation for Consolidation Therapy and Eight Recommendations for Maintenance Therapy. Overall
Consolidation Therapy with Chemotherapy Should Not Be Recommended in the Target Population. for Maintenance Therapy
We Recommended Olaparib (Recommendation)
Niraparib (Weak Recommendation)
Veliparib (Weak Recommendation)
and Bevacizumab (Weak Recommendation) for Certain Patients with Newly Diagnosed Stage III-IV Epithelial Ovarian
Fallopian Tube
Or
Primary
Peritoneal Carcinoma
Respectively. We Do Not Recommend Some Agents as Maintenance Therapy in Four Recommendations. We Are Unable to Specify the Patient Population by Histological Types for Different Maintenance Therapy Recommendations. When New Evidence That Can Impact the Recommendations Is Available
the Recommendations Will Be Updated as Soon as Possible.
指南简介
原文链接
Occult Primary
2021年 发布于
National Comprehensive Cancer Network
卷 第期
所属人体系统：
其他
|
不明原因癌症
National Comprehensive Cancer Network
Occult
Primary
cancer of Unknown
Primary
(CUP)
radiation Therapy
chemotherapy
follow-up
指南简介
原文链接
The 2020 Japan Society of Gynecologic Oncology Guidelines for the Treatment of Ovarian Cancer, Fallopian Tube Cancer, and Primary Peritoneal Cancer
2021年 发布于
Journal of Gynecologic Oncology
32卷 第2期
所属人体系统：
生殖
|
卵巢肿瘤
Japan Society of Gynecologic Oncology
The Fifth Edition of the Japan Society of Gynecologic Oncology Guidelines for the Treatment of Ovarian Cancer
Fallopian Tube Cancer
and
Primary
Peritoneal Cancer Was Published in 2020. the Guidelines Contain 6 Chapters-namely
(1) Overview of the Guidelines
(2) Epithelial Ovarian Cancer
Fallopian Tube Cancer
and
Primary
Peritoneal Cancer
(3) Recurrent Epithelial Ovarian Cancer
Fallopian Tube Cancer
and
Primary
Peritoneal Cancer
(4) Borderline Epithelial Tumors of the Ovary
(5) Malignant Germ Cell Tumors of the Ovary
and (6) Malignant Sex Cord-stromal Tumors. Furthermore
the Guidelines Comprise 5 Algorithms-namely
(1) Initial Treatment for Ovarian Cancer
Fallopian Tube Cancer
and
Primary
Peritoneal Cancer
(2) Treatment for Recurrent Ovarian Cancer
Fallopian Tube Cancer
and
Primary
Peritoneal Cancer
(3) Initial Treatment for Borderline Epithelial Ovarian Tumor
(4) Treatment for Malignant Germ Cell Tumor
and (5) Treatment for Sex Cord-stromal Tumor. Major Changes in the New Edition Include the Following: (1) Revision of the Title to "guidelines for the Treatment of Ovarian Cancer
Fallopian Tube Cancer
and
Primary
Peritoneal Cancer"
(2) Involvement of Patients and General (male/female) Participants in Addition to Physicians
Pharmacists
and Nurses
(3) Clinical Questions (CQs) in the PICO Format
(4) Change in the Expression of Grades of Recommendation and Level of Evidence in Accordance with the GRADE System
(5) Introduction of the Idea of a Body of Evidence
(6) Categorization of References According to Research Design
(7) Performance of Systematic Reviews and Meta-analysis for Three CQs
and (8) Voting for Each CQ/recommendation and Description of the Consensus.
指南简介
原文链接
An Ontario Health (Cancer Care Ontario) Clinical Practice Guideline: Consolidation Or Maintenance Systemic Therapy for Newly Diagnosed Stage Ii, Iii, Or Iv Epithelial Ovary, Fallopian Tube, Or Primary Peritoneal Carcinoma
2021年 发布于
Current Oncology
28卷 第2期
所属人体系统：
生殖
|
卵巢肿瘤
Ontario Health (Cancer Care Ontario)
Objective: to Provide Recommendations on Systemic Therapy Options in Consolidation Or Maintenance Therapy for Women with Newly Diagnosed Stage II
III
Or IV Epithelial Ovary
Fallopian Tube
Or
Primary
Peritoneal Carcinoma Including All Histological Types.
Methods: Consistent with the Program in Evidence-based Program's Standardized Approach
MEDLINE
EMBASE
PubMed
Cochrane Library
and PROSPERO (the International Prospective Register of Systematic Reviews) Databases
and Four Relevant Conferences Were Systematically Searched. the Working Group Drafted Recommendations and Revised Them Based on the Comments from Internal and External Reviewers.
Results: We Have One Recommendation for Consolidation Therapy and Eight Recommendations for Maintenance Therapy. Overall
Consolidation Therapy with Chemotherapy Should Not Be Recommended in the Target Population. for Maintenance Therapy
We Recommended Olaparib (Recommendation)
Niraparib (Weak Recommendation)
Veliparib (Weak Recommendation)
and Bevacizumab (Weak Recommendation) for Certain Patients with Newly Diagnosed Stage III-IV Epithelial Ovarian
Fallopian Tube
Or
Primary
Peritoneal Carcinoma
Respectively. We Do Not Recommend Some Agents as Maintenance Therapy in Four Recommendations. We Are Unable to Specify the Patient Population by Histological Types for Different Maintenance Therapy Recommendations. When New Evidence That Can Impact the Recommendations Is Available
the Recommendations Will Be Updated as Soon as Possible.
指南简介
原文链接
Colon Cancer
2021年 发布于
National Comprehensive Cancer Network
卷 第期
所属人体系统：
消化
|
结肠癌
National Comprehensive Cancer Network
Colon Cancer
primary Treatment
imaging
surgery
radiation and Chemoradiation Therapy
systemic Therapy
adjuvant Therapy
指南简介
原文链接
Esophageal and Esophagogastric Junction Cancers
2021年 发布于
National Comprehensive Cancer Network
卷 第期
所属人体系统：
消化
|
食管肿瘤
National Comprehensive Cancer Network
Esophageal Cancers
Esophagogastric Junction Cancers
treatment
primary Treatment
chemoradiation
follow-up
non-surgical
radiation Therapy
systemic Therapy
supportive Care
指南简介
原文链接
Head and Neck Cancers
2021年 发布于
National Comprehensive Cancer Network
卷 第期
所属人体系统：
其他
|
头颈部肿瘤
National Comprehensive Cancer Network
Head and Neck Cancers
treatment
Cancer of the Glottic Larynx
Cancer of the Hypopharynx
Cancer of the Lip (Mucosa)
Cancer of the Nasopharynx
Cancer of the Oral Cavity
Cancer of the Oropharynx
Cancer of the Supraglottic Larynx
Ethmoid Sinus Tumors
Head and Neck Cancers
Maxillary Sinus Tumors
Mucosal Melanoma
Occult
Primary
Salivary Gland Tumors
nutrition
urgery
systemic Therapy
imaging
radiation Therapy
指南简介
原文链接
Central Nervous System Cancers
2021年 发布于
National Comprehensive Cancer Network
卷 第期
所属人体系统：
神经
|
中枢神经系统肿瘤
National Comprehensive Cancer Network
Central Nervous System Cancers
Adult Intracranial and Spinal Ependymoma
Adult Low-Grade Glioma
Adult Medulloblastoma
Anaplastic Gliomas
Anaplastic Gliomas
Glioblastoma
Central Nervous System Cancers
Extensive Brain Metastases
Glioblastoma
Leptomeningeal Metastases
Limited Brain Metastases
Meningiomas
Metastatic Spine Tumors
Primary
CNS Lymphoma
Primary
Spinal Cord Tumors
imaging
surgery
radiation Therapy
systemic Therapy
pathology
指南简介
原文链接
Chinese Expert Consensus on the Clinical Application of Thiotepa in Hematological and Lymphatic System Tumors and Hematopoietic Stem Cell Transplantation (2020 Version)
2020年 发布于
Journal of Leukemia and Lymphoma
29卷 第期
所属人体系统：
循环
|
血液肿瘤
无
Acute
Hematopoietic Stem Cell Transplantation
Leukemia
Lymphoma
Non-Hodgkin
Primary
Central Nervous System Lymphoma
Sever Β-thalassemia
Thiotepa
指南简介
原文链接
PARP Inhibitors in the Management of Ovarian Cancer: ASCO Guideline
2020年 发布于
American Society of Clinical Oncology
卷 第期
所属人体系统：
生殖
|
卵巢肿瘤
American Society of Clinical Oncology
Ovarian Cancer
PARP Inhibitors
Management
treatment
epithelial Ovarian
Tubal
Or
Primary
Peritoneal Cancer (EOC)
指南简介
原文链接
Chinese Expert Consensus on Multiple Primary Cancers of Hypopharynx and Esophagus
2020年 发布于
Zhonghua Wai Ke Za Zhi
58卷 第8期
所属人体系统：
呼吸
|
下咽癌
Committee of Esophageal Cancer in China Anti-Cancer Association
Chinese Working Group on Cooperative Diagnosis and Treatment of Hypopharyngeal and Esophageal Cancer
Diagnosis
Esophageal Neoplasms
Hypopharyngeal Neoplasms
Neoplasms
Multiple
Primary
Treatment.
指南简介
原文链接
European Consensus-based Interdisciplinary Guideline for Melanoma. Part 1: Diagnostics - Update 2019
2020年 发布于
Eur J Cancer
126卷 第期
所属人体系统：
其他
|
黑色素瘤
European Dermatology Forum
European Association of Dermato-Oncology
European Organization of Research and Treatment of Cancer
AJCC Classification
Confocal Reflectance Microscopy
Cutaneous Melanoma
Dermatoscopy
Follow-up Examinations
Imaging Diagnostics
Mutation Testing
Primary
Diagnosis
Sequential Digital Dermatoscopy
Total Body Photography.
指南简介
原文链接
Impfprävention HPV-assoziierter Neoplasien. S3-LL (PEG)(English Title Translation: Primary Prevention of Neoplasms Associated to Human Papilloma Virus)
2020年
所属人体系统：
生殖
|
妇科肿瘤
Arbeitsgemeinschaft Der Wissenschaftlichen Medizinischen Fachgesellschaften
Neoplasms
Human Papilloma Virus
Primary
Prevention
指南简介
原文链接
Guideline on Screening for Esophageal Adenocarcinoma in Patients with Chronic Gastroesophageal Reflux Disease
2020年
所属人体系统：
消化
|
食管肿瘤
Canadian Task Force on Preventive Health Care
Clinical Practice Guidelines
Evidence-based Medicine
Family Medicine
Primary
Care
Esophageal Adenocarcinoma
指南简介
原文链接
首页
1
2
3
下一页
尾页
共52条，每页显示
20条
50条
100条
跳转至第
页
确定
